Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox plus diltiazem ointment for chronic anal fissure
IRCT20151020024625N13Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A and diltiazem in chronic anal fissure (CAF), sponsored by Semnan University of Medical Sciences. Started Jun 2021; status: completed.
02
Drugs
botulinum toxin type Adiltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on IRCT20151020024625N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151020024625N13.